[PHARMA] QoQ Annualized Quarter Result on 31-Mar-2011 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
13-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Mar-2011 [#1]
Profit Trend
QoQ- 103.84%
YoY- 66.37%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Revenue 1,520,981 1,537,593 1,563,526 1,541,312 1,378,348 1,336,309 1,335,790 9.01%
PBT 73,186 75,757 82,344 87,168 45,462 64,217 65,516 7.63%
Tax -20,401 -21,620 -23,056 -24,772 -15,152 -21,201 -17,862 9.23%
NP 52,785 54,137 59,288 62,396 30,310 43,016 47,654 7.03%
-
NP to SH 52,157 53,620 58,808 61,936 30,384 43,520 48,108 5.51%
-
Tax Rate 27.88% 28.54% 28.00% 28.42% 33.33% 33.01% 27.26% -
Total Cost 1,468,196 1,483,456 1,504,238 1,478,916 1,348,038 1,293,293 1,288,136 9.08%
-
Net Worth 514,273 464,307 451,381 437,661 421,524 424,715 417,306 14.90%
Dividend
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Div 35,304 - - - 10,698 67,041 100,581 -50.14%
Div Payout % 67.69% - - - 35.21% 154.05% 209.07% -
Equity
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Net Worth 514,273 464,307 451,381 437,661 421,524 424,715 417,306 14.90%
NOSH 117,682 106,983 106,962 107,007 106,985 106,981 107,001 6.53%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
NP Margin 3.47% 3.52% 3.79% 4.05% 2.20% 3.22% 3.57% -
ROE 10.14% 11.55% 13.03% 14.15% 7.21% 10.25% 11.53% -
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 1,292.44 1,437.23 1,461.75 1,440.38 1,288.35 1,249.11 1,248.38 2.33%
EPS 44.32 50.12 54.98 57.88 28.40 40.68 44.96 -0.94%
DPS 30.00 0.00 0.00 0.00 10.00 62.67 94.00 -53.20%
NAPS 4.37 4.34 4.22 4.09 3.94 3.97 3.90 7.85%
Adjusted Per Share Value based on latest NOSH - 107,007
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 105.53 106.69 108.49 106.94 95.64 92.72 92.68 9.01%
EPS 3.62 3.72 4.08 4.30 2.11 3.02 3.34 5.49%
DPS 2.45 0.00 0.00 0.00 0.74 4.65 6.98 -50.14%
NAPS 0.3568 0.3222 0.3132 0.3037 0.2925 0.2947 0.2895 14.90%
Price Multiplier on Financial Quarter End Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 -
Price 5.36 5.90 5.90 5.73 5.31 4.98 4.98 -
P/RPS 0.41 0.41 0.40 0.40 0.41 0.40 0.40 1.65%
P/EPS 12.09 11.77 10.73 9.90 18.70 12.24 11.08 5.97%
EY 8.27 8.49 9.32 10.10 5.35 8.17 9.03 -5.67%
DY 5.60 0.00 0.00 0.00 1.88 12.58 18.88 -55.42%
P/NAPS 1.23 1.36 1.40 1.40 1.35 1.25 1.28 -2.61%
Price Multiplier on Announcement Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 22/02/12 01/11/11 10/08/11 13/05/11 25/02/11 04/11/10 11/08/10 -
Price 5.90 5.90 5.90 5.05 5.35 4.92 4.95 -
P/RPS 0.46 0.41 0.40 0.35 0.42 0.39 0.40 9.73%
P/EPS 13.31 11.77 10.73 8.72 18.84 12.09 11.01 13.44%
EY 7.51 8.49 9.32 11.46 5.31 8.27 9.08 -11.85%
DY 5.08 0.00 0.00 0.00 1.87 12.74 18.99 -58.38%
P/NAPS 1.35 1.36 1.40 1.23 1.36 1.24 1.27 4.14%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment